activins has been researched along with Cardiovascular Stroke in 9 studies
Activins: Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ramipril is a recently developed angiotensin converting enzyme (ACE) inhibitor." | 5.43 | Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure. ( Liu, H; Liu, M; Liu, Z; Wei, Q; Yang, C; Yang, J; Yang, P, 2016) |
| "The number and degree of stenosis were recorded." | 2.84 | Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK ( Anastasilakis, AD; Anastasilakis, CD; Economou, F; Kefala, N; Koulaxis, D; Mantzoros, CS; Pagkalidou, E; Polyzos, SA; Upadhyay, J, 2017) |
| "Ramipril is a recently developed angiotensin converting enzyme (ACE) inhibitor." | 1.43 | Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure. ( Liu, H; Liu, M; Liu, Z; Wei, Q; Yang, C; Yang, J; Yang, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anastasilakis, AD | 1 |
| Koulaxis, D | 1 |
| Kefala, N | 1 |
| Polyzos, SA | 1 |
| Upadhyay, J | 1 |
| Pagkalidou, E | 1 |
| Economou, F | 1 |
| Anastasilakis, CD | 1 |
| Mantzoros, CS | 1 |
| Hu, J | 1 |
| Wang, X | 1 |
| Tang, YH | 1 |
| Shan, YG | 1 |
| Zou, Q | 1 |
| Wang, ZQ | 1 |
| Huang, CX | 1 |
| Wei, Q | 2 |
| Wang, YN | 1 |
| Liu, HY | 1 |
| Yang, J | 2 |
| Yang, CY | 1 |
| Liu, M | 2 |
| Liu, YF | 1 |
| Yang, P | 2 |
| Liu, ZH | 1 |
| Ofstad, AP | 1 |
| Gullestad, L | 1 |
| Orvik, E | 1 |
| Aakhus, S | 1 |
| Endresen, K | 1 |
| Ueland, T | 2 |
| Aukrust, P | 2 |
| Fagerland, MW | 1 |
| Birkeland, KI | 1 |
| Johansen, OE | 1 |
| Liu, H | 1 |
| Yang, C | 1 |
| Liu, Z | 1 |
| Panteghini, M | 1 |
| Tate, JR | 1 |
| Miyoshi, T | 1 |
| Hirohata, S | 1 |
| Uesugi, T | 1 |
| Hirota, M | 1 |
| Ohnishi, H | 1 |
| Nogami, K | 1 |
| Hatanaka, K | 1 |
| Ogawa, H | 1 |
| Usui, S | 1 |
| Kusachi, S | 1 |
| Oshima, Y | 1 |
| Ouchi, N | 1 |
| Shimano, M | 1 |
| Pimentel, DR | 1 |
| Papanicolaou, KN | 1 |
| Panse, KD | 1 |
| Tsuchida, K | 1 |
| Lara-Pezzi, E | 1 |
| Lee, SJ | 1 |
| Walsh, K | 1 |
| Andersen, GØ | 1 |
| Knudsen, EC | 1 |
| Scholz, H | 1 |
| Yndestad, A | 1 |
| Sahraoui, A | 1 |
| Smith, C | 1 |
| Lekva, T | 1 |
| Otterdal, K | 1 |
| Halvorsen, B | 1 |
| Seljeflot, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Asker and Baerum Cardiovascular Diabetes Study[NCT00133718] | Phase 4 | 120 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| Randomised Controlled Trial Into the Role of Ramipril in Fibrosis Reduction in Rheumatic Heart Disease: The RamiRHeD Trial Protocol[NCT03991910] | Phase 3 | 66 participants (Anticipated) | Interventional | 2019-06-27 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for activins and Cardiovascular Stroke
| Article | Year |
|---|---|
Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK
Topics: Activins; Aged; Case-Control Studies; Constriction, Pathologic; Coronary Angiography; Coronary Arter | 2017 |
8 other studies available for activins and Cardiovascular Stroke
| Article | Year |
|---|---|
Activin A inhibition attenuates sympathetic neural remodeling following myocardial infarction in rats.
Topics: Activins; Animals; Biomarkers; Cytokines; Disease Models, Animal; Follistatin; Heart Function Tests; | 2018 |
The expression and role of activin A and follistatin in heart failure rats after myocardial infarction.
Topics: Activins; Animals; Follistatin; Heart Failure; Inhibin-beta Subunits; Myocardial Infarction; Rats | 2013 |
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.
Topics: Activins; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Squar | 2013 |
Ramipril attenuates left ventricular remodeling by regulating the expression of activin A-follistatin in a rat model of heart failure.
Topics: Activins; Animals; Biomarkers; Biopsy; Disease Models, Animal; Female; Fibrosis; Follistatin; Gene E | 2016 |
Measurement of activin A in acute myocardial infarction: is there a clinical role?
Topics: Activins; Animals; Biomarkers; Humans; Myocardial Infarction | 2009 |
Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention.
Topics: Activins; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Creatine Kinase; Creatine Kinase, M | 2009 |
Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.
Topics: Activin Receptors; Activins; Animals; Animals, Newborn; Apoptosis; Cell Hypoxia; Cell Survival; Cell | 2009 |
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation.
Topics: Activins; Aged; Blood Glucose; Female; Glucose Tolerance Test; Humans; Immunoenzyme Techniques; Infl | 2011 |